A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. I'm back in ...
Valneva SE (NASDAQ: VALN) shared final immunogenicity and safety data on Wednesday from the Phase 2 study, VLA15-221, of the Lyme disease vaccine candidate, VLA15. Lyme disease is a bacterial ...
President Donald Trump has demanded that pharmaceutical companies such as Pfizer release what he described as hidden COVID-19 vaccine data, raising questions about the legacy of Operation Warp Speed, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results